Interested in trying Viagra or similar ED medication? Consider an ED consultation with a Hims’ healthcare professional to learn more about your options for treating and preventing ED.

But Hims & Hers Health Inc. — the online telehealth platform best known for selling hair-loss treatments, Viagra and Cialis — said customers are still piling in. The company on Monday bumped ...

The ad is for Hims, a men's health startup know for selling generic Viagra and hair-loss medications. It's an approach that's getting a lot of attention as investors are wagering that consumers ...

Brand-name Viagra is also available through Roman in 25-, 50-, or 100-mg pills for $90 per dose. To purchase medication from telehealth company Hims, you’ll need to complete a health ...

We include products we think are useful for our readers. If you buy through links on this page, we may earn a small commission or other tangible benefit. Optum Store, Optum Perks, and Healthline ...

Advertiser Disclosure. Hims is an online telehealth platform for men that provides care for mental health, sexual health, hair loss, skincare and more. Outside of offering telehealth appointments ...

No sildenafil – If you’re looking for sildenafil, the active ingredient in Viagra, unfortunately Hims hard mints no longer contain that active ingredient. Erectile dysfunction affects each ...

Hims Hard Mints uses a compound of sildenafil and tadalafil, the active ingredients in Viagra and Cialis, to create a chewable pill. One large difference between the Hard Mints and traditional ...

Hims & Hers Health Q3 2024 revenue projected to surpass estimates by $5M-$10M. Truist consumer survey shows 10% use compounded GLP-1 medications, while 14% prefer branded options. Thursday, The ...

Shares of Hims & Hers Health fell almost 10% today following an announcement from the U.S. Food and Drug Administration (FDA) that competitor Eli Lilly’s obesity and diabetes drugs are no longer ...

Hims & Hers (NYSE:HIMS), the telehealth platform that offers compounded versions of weight loss drugs, dropped more than 10% on Thursday after the FDA confirmed that Eli Lilly's (LLY) GLP-1 ...